| February 25, 2014 | Strengthening of petrochemical operations in Japan Presentation Materials |
|---|---|
| February 25, 2014 | Basic agreement on unification of naphtha cracker facilities in Mizushima |
| February 20, 2014 | Dr. Akira Yoshino awarded the Charles Stark Draper Prize |
| February 7, 2014 | Completion of the second manufacturing facility at the Nagoya Pharmaceuticals Plant |
| January 31, 2014 | Discontinuation of the development of a transdermal patch formulation of Teribone™ human parathyroid hormone |
|---|---|
| January 24, 2014 | Change in Representative Directors |
| January 8, 2014 | Dr. Akira Yoshino chosen for the Charles Stark Draper Prize |
| December 12, 2013 | ZOLL Foundation Established |
|---|---|
| December 9, 2013 | Approval in Japan for manufacturing and marketing of the X Series® defibrillator for emergency medical and hospital use |
| October 28, 2013 | Completion of a new research complex in the Pharmaceuticals Research Center |
|---|---|
| October 24, 2013 | Launch of AK09911C, a new 3-axis electronic compass for portable appliances |
| October 1, 2013 | Launch of drug discovery collaboration with Vernalis plc |
| September 30, 2013 | Conclusion of Co-promotion agreement on Recomodulin™ anticoagulant intravenous infusion 12800 |
|---|
| August 29, 2013 | Construction of new plant for polycarbonatediol in China |
|---|---|
| August 8, 2013 | Initiation of local manufacture of polyamide 66 compounds in Indonesia |
| August 6, 2013 | Launch of mycoplasma antigen kit Ribotest™ Mycoplasma |
| August 2, 2013 | Progress in study for unification of naphtha cracker facilities in Mizushima |
| July 24, 2013 | Approval in Japan for manufacturing and marketing of LifeVest® Wearable Cardioverter Defibrillator |
|---|---|
| July 12, 2013 | Grand opening ceremony for new solution SBR plant in Singapore |
| June 24, 2013 | Dr. Akira Yoshino awarded the Global Energy Prize |
|---|---|
| June 10, 2013 | Obtaining full ownership of polyacetal joint venture in China |
| May 27, 2013 | Progress and outlook under strategic management initiative “For Tomorrow 2015” Presentation materials, Audio (Windows Media), Transcript |
|---|---|
| May 24, 2013 | Announcement of listing on the NHI drug price standard and marketing of NEOXY® Tape 73.5 mg, transdermal overactive bladder treatment medication |
| April 24, 2013 | License of PMMA manufacturing technology in Thailand |
|---|---|
| April 22, 2013 | Dissolution of the exclusive right for sale of Reveal® DX |
| April 19, 2013 | Dr. Akira Yoshino chosen for the Global Energy Prize |
| April 12, 2013 | Receipt of Pirelli Supplier Award |
| April 11, 2013 | Expansion of capacity in China for Duranate™ |
Adobe Readeris required to view these PDF files.